Colgate Palmolive (India) Limited COLPAL
Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.
Loading prices…
Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.Test a strategy on COLPAL
Real prices, every charge counted. Pick one or write your own.Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.
EOD 13 NovThe share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Are its options cheap or dear?It compares the movement option prices assume with the movement the share has actually shown.
Live in market hoursImplied volatility needs the live option chain, which is open 9:15 to 3:30.
Returns and valuationWhat the market pays for this company and how well the business uses its money.
Books to 30 Sept 2026Against its sectorWhere this company ranks among similar companies on each measure.
Personal Care · 13 peers · mediansWhat the numbers sayShort plain statements about this company's latest figures.
Written by fixed rulesLatest quarterIn the quarter to September 2026 (results filed 22 Oct 2026), sales rose 12.3% from a year earlier to ₹1,706 cr and profit rose 4.3% to ₹342 cr.
- Return on equity stayed above 15% from FY24 to FY26 (lowest 73.7%).
- No borrowings at the FY26 balance sheet.
- Foreign institutions cut their holding by 6.7 points over 5 quarters (20.39% to 13.71%).
- Domestic institutions raised their holding by 5.8 points over 5 quarters (9.62% to 15.46%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
How the share moved on resultsWhat the share price did around each recent quarterly result.
Over the last 20 results, the share rose on 8 and fell on 12, and moved by 3% or more on 8.
Q2 FY27: results filed 22 Oct 2026. The share went from its close on 21 Oct 2026 to its close on 23 Oct 2026 -6.69%.
Dividends paidCash the company has paid per share, year by year.
2026 has paid ₹48.00 per share, about ₹2,800 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.
What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.
Price only, before dividendsHeld for 15 years this compounded at +8.2% a year. The last twelve months were down -21.2%. Price only, before dividends.
Who owns itThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.
Shareholding patternEach line is that holder's share of all shares over the last 6 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.
The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.
Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.
Last 6 monthsAt a glanceThe eight figures most people check first, each placed against companies in the same industry.
Against its sectorPeers are the listed companies in the exchange's own industry group: Personal Care. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
The business, year by yearSales and net profit by financial year or by quarter.
Sales and net profitWhere every ₹100 of sales goesHow each ₹100 the company sold was spent, and how much stayed as profit.
FY26In FY26, of every ₹100 of sales it kept ₹22.0 as profit. Other income added ₹1.5.
How fast it has grownCompound growth a year in sales and profit, over 3 and 5 financial years, beside the latest quarter.
Compounded a yearWhere the cash wentProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.
From the cash flow statementIn FY26 cash rose by ₹758 Cr, after ₹76 Cr spent on plant and equipment.
Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.
| Measure | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales growthSales in this financial year against the previous one. | 2.5% | 8.7% | 6.3% | -0.1% |
| Operating marginOf every ₹100 of sales, the profit from the main business before depreciation, interest and tax. | 29.6% | 33.5% | 32.4% | 31.0% |
| Net marginOf every ₹100 of sales in the year, how much was left as profit after everything. | 20.0% | 23.3% | 23.8% | 22.0% |
| ROEHow much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | 61.0% | 73.7% | 81.2% | 81.6% |
| ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders. | 82.4% | 99.5% | 109% | 110% |
| Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | 0.00x | 0.00x | 0.00x | 0.00x |
| Interest coverHow many times the company's profit before interest could pay its interest bill. | 289x | 357x | 450x | 470x |
Each row against this company's own usual level: green better, red worse, grey close to it.
Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.
Personal Care| Company | What the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality. | How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit. | The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business. | How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money. | How much operating profit the company made on all the money in the business, whether it came from owners or lenders. | Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings. | Of every ₹100 of sales, how much is left as profit after all costs, interest and tax. | How much sales grew in the latest quarter against the same quarter a year earlier. | The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share. |
|---|---|---|---|---|---|---|---|---|---|
| GODREJCP Godrej Consumer Products Limited | 89,104 cr | 45.0x | 7.1x | 15.1% | 17.9% | 0.37 | 11.9% | +15.4% | 2.30% |
| DABUR Dabur India Limited | 67,499 cr | 33.3x | 5.9x | 16.2% | 20.7% | 0.10 | 14.4% | +11.7% | 2.37% |
| CUPID Cupid Limited | 50,801 cr | 299.8x | 90.3x | 27.3% | 33.9% | 0.19 | 30.5% | +122.5% | 0.00% |
| COLPAL Colgate Palmolive (India) Limited | 46,618 cr | 34.2x | 28.8x | 81.6% | 110.1% | 0.00 | 21.3% | +12.3% | 2.80% |
| GILLETTE Gillette India Limited | 23,615 cr | 34.5x | 22.0x | 69.1% | 94.3% | 0.00 | 21.3% | +4.3% | 4.14% |
| PGHH Procter & Gamble Hygiene and Health Care Limited | 22,820 cr | 29.4x | 25.8x | 113.7% | 156.1% | 0.00 | 18.3% | -0.4% | 3.63% |
| EMAMILTD Emami Limited | 17,814 cr | 23.9x | 6.1x | 27.6% | 29.7% | 0.06 | 17.8% | +36.2% | 3.68% |
| HONASA Honasa Consumer Limited | 16,365 cr | 57.8x | 11.0x | 15.4% | 20.9% | 0.00 | 10.3% | +35.9% | 0.60% |
| BAJAJCON Bajaj Consumer Care Limited | 5,640 cr | 22.8x | 6.3x | 25.3% | 31.0% | 0.00 | 19.2% | +25.5% | 0.00% |
| ANONDITA Anondita Medicare Limited | 2,024 cr | 50.9x | 15.7x | - | 31.0% | 0.26 | 25.0% | - | 0.00% |
| MACOBSTECH Macobs Technologies Limited | 192 cr | 72.3x | 6.2x | - | 13.4% | 0.06 | 7.7% | - | 0.00% |
| AAKAAR Aakaar Medical Technologies Limited | 98 cr | 8.9x | 1.7x | - | 15.0% | 0.33 | 12.8% | +72.7% | 0.00% |
| JHS JHS Svendgaard Laboratories Limited | 70 cr | - | 0.4x | -1.1% | -0.8% | 0.08 | -1.1% | -2.0% | 0.00% |
| MEDISTEP Medistep Healthcare Limited | 26 cr | - | 0.7x | - | - | 0.02 | - | - | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Month by monthThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.
Price return each month| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.9 | +6.6 | -20.7 | +17.2 | -1.7 | -2.9 | +3.8 | -8.6 | -7.1 | -9.5 | +7.4 | · | -17.4% 11m |
| 2025 | +5.3 | -12.7 | -3.0 | +8.3 | -5.1 | -2.0 | -6.7 | +3.9 | -4.7 | +0.9 | -3.3 | -4.3 | -22.6% |
| 2024 | +1.6 | -1.6 | +7.3 | +4.2 | -5.9 | +7.0 | +20.0 | +6.7 | +4.5 | -19.5 | -5.6 | -7.2 | +6.0% |
| 2023 | -5.4 | +1.4 | +2.3 | +5.8 | -0.2 | +6.1 | +19.6 | -3.8 | +3.3 | +5.4 | +3.9 | +15.2 | +64.7% |
| 2022 | -3.8 | +1.8 | +6.3 | +7.3 | -1.6 | -8.6 | +6.7 | +5.6 | -2.7 | +0.1 | +0.0 | -5.9 | +3.7% |
| 2021 | +2.4 | -1.4 | -1.4 | -5.0 | +16.1 | -2.0 | +1.1 | -0.7 | -1.4 | -7.6 | -7.0 | +3.3 | -5.4% |
| 2020 | -9.2 | -3.3 | -2.5 | +16.5 | -4.6 | +1.1 | +1.2 | -4.2 | +5.2 | +5.8 | -0.2 | +3.4 | +7.0% |
| 2019 | -4.7 | -1.9 | +0.1 | -4.0 | -4.6 | -2.1 | +5.5 | +7.1 | +18.0 | +3.0 | -4.8 | -0.8 | +8.9% |
| 2018 | +1.9 | -7.2 | +1.5 | +6.3 | +12.2 | -5.9 | -3.3 | +2.1 | -7.5 | +3.3 | +9.1 | +10.2 | +22.1% |
| 2017 | -1.9 | +1.4 | +10.6 | +4.0 | -2.0 | +9.5 | -2.8 | +3.1 | -4.1 | -0.2 | -2.6 | +6.1 | +21.6% |
Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.
Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.
| Date | Party | Side | Quantity | Price | Value |
|---|---|---|---|---|---|
| 2022-11-14 | ISHARES CORE MSCI EMERGING MARKETS ETF · block | BUY | 1,92,355 | ₹1,585.85 | ₹30.50 Cr |
| 2022-11-14 | ISHARES CORE EMERGING MARKETS MAURITIUS CO · block | SELL | 1,92,355 | ₹1,585.85 | ₹30.50 Cr |
| 2022-10-03 | ISHARES CORE MSCI EMERGING MARKETS ETF · block | BUY | 1,59,120 | ₹1,629.40 | ₹25.93 Cr |
| 2022-10-03 | ISHARES CORE EMERGING MARKETS MAURITIUS CO · block | SELL | 1,59,120 | ₹1,629.40 | ₹25.93 Cr |
| 2022-08-08 | ISHARES MSCI INDIA ETF · block | BUY | 1,44,736 | ₹1,614.10 | ₹23.36 Cr |
| 2022-08-08 | ISHARES INDIA INDEX MAURITIUS COMPANY · block | SELL | 1,44,736 | ₹1,614.10 | ₹23.36 Cr |
| 2022-07-25 | ISHARES MSCI INDIA ETF · block | BUY | 1,44,736 | ₹1,605.90 | ₹23.24 Cr |
| 2022-07-25 | ISHARES INDIA INDEX MAURITIUS COMPANY · block | SELL | 1,44,736 | ₹1,605.90 | ₹23.24 Cr |
- Press releasePress Release22 Oct 2026
Colgate Palmolive (India) Limited has informed the Exchange regarding a press release dated October 22, 2026, titled "Announcement of Results for the Quarter Ended September 30, 2026".
- Board outcomeOutcome of Board Meeting22 Oct 2026
Colgate Palmolive (India) Limited has informed the Exchange that Board of Directors at its meeting held on October 22, 2026, approved Financial Results
- Press releasePress Release29 Jul 2026
Colgate Palmolive (India) Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Please find herewith enclosed News Release- Announcement of Results for the Quarter Ended June 30, 2026".
- Board outcomeOutcome of Board Meeting29 Jul 2026
Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
- Press releasePress Release22 May 2026
Colgate Palmolive (India) Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Announcement of results for the quarter and year ended March 31, 2026".
- Board outcomeOutcome of Board Meeting22 May 2026
Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
- Board outcomeOutcome of Board Meeting29 Jan 2026
Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
- Board outcomeOutcome of Board Meeting23 Oct 2025
Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
- Board outcomeOutcome of Board Meeting22 Jul 2025
Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
- Board outcomeOutcome of Board Meeting21 May 2025
Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.
- Integrated Filing- Financial28 Jan 2025
Please find enclosed herewith Integrated Filing (Financial) for the quarter ended December 31, 2024
- Financial Result Updates28 Jan 2025
Colgate Palmolive (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
The last two years of the company's filings to the exchange, grouped by the exchange's own categories. Each opens the original document.
Read enough? Test COLPAL. “Buy COLPAL when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.
Run it free